US Broker Ratings

89bio, Inc. (ETNB): Analyst Consensus Points to a 191% Upside Potential

For investors with a focus on the biotechnology sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing proposition. With a market capitalization of $1.48 billion, this San Francisco-based clinical-stage biopharmaceutical company..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Bet with 79% Potential Upside

For investors with an eye on the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling opportunity. With a market capitalization of $1.75 billion, the San Diego-based company specializes..

Liquidia Corporation (LQDA)

⚠️ No article content returned.

..

Enovis Corporation (ENOV) Stock Analysis: Exploring a Potential 114.83% Upside

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, specifically in the realm of medical devices, is capturing investor attention with its substantial potential upside of 114.83%. As..

Bausch Health Companies Inc. (BHC): Investor Outlook and 12% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC) presents an intriguing opportunity for investors eyeing the healthcare sector. With a market capitalization of $2.34 billion, this Canadian pharmaceutical giant is a notable..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Investor Outlook with 17.74% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a key player in the Healthcare sector, operates within the Medical Care Facilities industry. With a market capitalization nearing $929 million, HCSG offers a..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring a 46.96% Upside Potential in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a pioneering player in the healthcare sector, is attracting investor attention with its innovative bioelectric medicine solutions. Specializing in the development and commercialization of the..

Innoviva, Inc. (INVA) Stock Analysis: Uncovering a Potential 182% Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently capturing the attention of investors with a remarkable potential upside of 182%. As a healthcare-focused entity, Innoviva..

Phreesia, Inc. (PHR) Stock Analysis: A 19% Potential Upside in Healthcare SaaS

Phreesia, Inc. (PHR), a prominent player in the healthcare information services sector, has been making waves with its robust growth metrics and promising analyst projections. Specializing in a SaaS-based platform..

Mesoblast Limited (MESO) Stock Analysis: Unveiling an 84% Potential Upside for Investors

Mesoblast Limited (NASDAQ: MESO), a pioneering biotech company in the healthcare sector, is capturing investor attention with its promising regenerative medicine platform. Headquartered in Melbourne, Australia, Mesoblast specializes in developing..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 31% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out in the biotechnology industry with its commitment to developing innovative treatments for rare disorders. Headquartered in Warren, New Jersey, this biopharmaceutical company has..

Kymera Therapeutics (KYMR) Stock Analysis: Impressive Revenue Growth and Strong Buy Ratings Signal Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biotechnology firm at the cutting edge of therapeutic development, is captivating the attention of investors with its promising portfolio and substantial growth metrics. As..

Artivion, Inc. (AORT) Stock Analysis: A Strong Buy Rating with a 6.77% Upside Potential

Artivion, Inc. (NASDAQ: AORT), a key player in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a notable market cap of $1.44 billion. The..

Apellis Pharmaceuticals (APLS) Stock Analysis: A Biotech Powerhouse with 83% Upside Potential

For investors with an eye on the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a compelling opportunity. With a market capitalization of $2.42 billion, this U.S.-based biopharmaceutical company is..

Neogen Corporation (NEOG) Stock Analysis: Unveiling a 56.9% Potential Upside for Investors

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, offers a compelling investment opportunity with a notable potential upside of 56.9%. This Michigan-based..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unpacking the 320.97% Potential Upside and Strong Analyst Confidence

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its ambitious pipeline targeting chronic diseases. With a market capitalization of $1.04 billion,..

Vericel Corporation (VCEL) Stock Analysis: Unveiling a 63.92% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) has been making waves in the biotechnology sector, appealing to investors with its innovative approach to cellular therapies and specialty biologics. As a commercial-stage biopharmaceutical company,..

National HealthCare Corporation (NHC) Stock Analysis: Evaluating the 25.7% Revenue Growth in the Healthcare Sector

As the U.S. healthcare industry continues to navigate the complexities of an aging population and evolving medical needs, National HealthCare Corporation (NHC) emerges as a key player worth scrutinizing. With..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A 42.68% Potential Upside Opportunity in the Healthcare Sector

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is capturing the attention of investors seeking opportunities in the healthcare sector. With a potential upside of 42.68%, as indicated by analyst target prices,..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 4.01% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a formidable player in the health information services industry, continues to capture investor attention with its strategic operations in healthcare improvement. Headquartered in Charlotte, North Carolina,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds